Skip to content
Search

Latest Stories

Darzi report reveals NHS is in critical condition, pharmacy bodies urge immediate action

Darzi report reveals NHS is in critical condition, pharmacy bodies urge immediate action

Pharmacy organisations are hopeful that the Darzi report will prompt ministers to take swift action to tackle the chronic underfunding that is driving pharmacy closures 

The Department of Health and Social Care (DHSC) has published Lord Darzi's report on the state of NHS England, which revealed that the health service is in "serious trouble."


Lord Darzi pointed out that the NHS has failed to meet key promises made to the public since 2015 and patient satisfaction is now at its lowest ever level.

Rising waiting times and difficulties accessing GPs were highlighted as major concerns.

“There are huge and unwarranted variations in the number of patients per GP, and shortages are particularly acute in deprived communities,” the report said.

Darzi described the state of A&E as “awful”, noting that nearly 10 per cent of patients wait 12 hours or more today.

Additionally, Lord Darzi's investigation found that the NHS budget is not being optimally allocated, noting that “too great a share is being spent in hospitals, too little in the community, and productivity is too low.”

The report identified four inter-related factors contributing to the NHS current dire state:

  1. Austerity in funding and capital starvation
  2. The impact of the Covid-19 pandemic and its aftermath
  3. Lack of patient voice and staff engagement
  4. Inefficient management structures and systems

Despite these challenges, Darzi remains optimistic about the NHS's future as he concluded that the “NHS is in critical condition, but its vital signs are strong.”

He acknowledged the massive gap in capital investment but noted that the NHS has more resources than ever.

However, he warned that restoring the NHS to peak performance will take time and will likely extend beyond a single parliamentary term.

Reaction from pharmacy bodies

Pharmacy organisations are hopeful that the report’s findings will prompt ministers to take swift action to tackle the chronic underfunding that is driving pharmacy closures.

Paul Rees, Chief Executive of the National Pharmacy Association (NPA), said: “Lord Darzi’s report must spur Ministers into immediate action to end the scandal of pharmacy closures caused by chronic underfunding over many years, that is eating away at frontline patient care.

“With pharmacies closing at the rate of seven a week and so many more teetering on the brink, the millions who use pharmacies simply can’t wait. They need action now.”

He emphasised that modest investment to ensure adequate pharmacy funding could “transform frontline care, end the scramble for doctors’ appointments, and help fix the NHS fast.”

Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA), welcomed the report's findings and its acknowledgment of the critical state of NHS and community pharmacy.

Harrison highlighted the severe impact of a 30 per cent real terms cut in funding since 2015, which led to the closure of over 1,200 pharmacies.

He stressed that, unlike the NHS, the productivity in the community pharmacy has increased, despite a shrinking funding pot.

“Between 2017/18 and 2023/24, the number of items dispensed each year grew by over 100m. In the same period, the number of clinical services delivered in community pharmacies increased by over 115 per cent with community pharmacies delivering over 12m services in 2023/24.”

“The review rightly points out that there is huge potential to harness the clinical capabilities of pharmacists. Expansion of Pharmacy First, which the report describes as a “notable success” is key – a fully-fledged service could free up 30m+ GP appointments each year.

Similarly, pharmacies can play an even bigger role in administering vaccinations as the report rightly highlights concerns around declining uptake.”

However, he noted that an expanded role for community pharmacy is only possible if there is action to protect the existing community pharmacy network through additional investment.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less